Journal Information
Vol. 15. Issue 2.
Pages 126-131 (March - April 2011)
Share
Share
Download PDF
More article options
Vol. 15. Issue 2.
Pages 126-131 (March - April 2011)
Original article
Open Access
Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions
Visits
3093
Luciane Noal Calil1,
Corresponding author
luciane1011@gmail.com

Correspondence to: Avenida Ipiranga, 2752, 3° Andar, Laboratório 304D, 90610-000, Rio Branco, Porto Alegre, RS Fax: +55 51 33085437, Phone: +55 51 33085276.
, Cristine Nascente Igansi2, Luise Meurer3, Maria Isabel Albano Edelweiss4, Mary Clarisse Bozzetti5
1 Professor, Post-graduate Program in Medical Sciences, Faculty of Pharmacy, Post-graduate Program in Epidemiology at Universidade Federal do Rio Grande do Sul - UFRGS; Hospital de Clínicas de Porto Alegre - HCPA, Porto Alegre, Brazil
2 Brazilian Ministry of Health Epidemiologist
3 Pathologist, HCPA, Porto Alegre, Brazil
4 Associated Professor, UFRGS, Porto Alegre, Brazil
5 Associated Professor, UFRGS, Porto Alegre, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

The objective of this study was to identify the frequency of coinfection by human papillomavirus (HPV) and Chlamydia trachomatis (CT) in cervical lesions and relate it with immunohistochemical expression of p16INK4a and Ki67, both oncogenicity markers. A cross-sectional study with 86 women from primary care units in southern Brazil was conducted. Cervical swabs were collected for HPV-DNA and CT-DNA detection, through the polymerase chain reaction technique (PCR). The immunohistochemical analysis was performed on biopsy cervical tissue material to identify the expression of p16INK4a and Ki67 cell cycle markers. About 83 % were positive for HPV-DNA and 19% had coinfection with CT-DNA. Among coinfected women, 56% expressed p16INK4a. There was a statistically significant association between the histological grade of the lesion and Ki67 expression. All high-grade lesions, 50% of low-grade lesions and 31% of negative biopsies expressed Ki67 (p=0.004). A total of 37% of coinfected women expressed both markers. In conclusion, although more than half of the coinfected patients have expressed p16INK4a and more than one third have expressed both markers, these results suggest no association between those variables. However, other studies involving larger samples are necessary to corroborate such findings.

Keywords:
epidemiology
human papillomavirus 16
biomarkers
pharmacological
Full text is only aviable in PDF
References
[1.]
C. Velicer, X. Zhu, S. Vuocolo, et al.
Prevalence and incidence of HPV genital infection in women.
Sex Transm Dis, 36 (2009), pp. 696-703
[2.]
F.J. Bilardi, C.K. Fairley, C.A. Hopkins, et al.
Experiences and Outcomes of partner notification among men and women recently diagnosed with Chlamydia and their views on innovative resources aimed at improving notification rates.
Sex Transm Dis, 37 (2010), pp. 253-258
[3.]
K.L. Wallin, F. Wiklund, T. Luostarinen, et al.
A populationbased prospective study of Chlamydia trachomatis infection and cervical cancer carcinoma.
Int J Cancer, 101 (2002), pp. 371-374
[4.]
V.K. Doeberitz.
New markers for cervical dysplasia to visualise the genomic chaos created by oncogenic human papillomavirus infections.
Eur J Cancer, 38 (2002), pp. 2229-2242
[5.]
C. Queiroz, T.C. Silva, V.A.F. Alves, et al.
p16INK4a and Ki67 expression as a potential prognostic marker in ceical preneoplastic and neoplastic lesions.
Pathology Research and Practice, 202 (2006), pp. 77-83
[6.]
M. Benevolo, M. Mottolese, F. Marandino, et al.
Immunohistochemical expression of p16INK4a is predictive of HRHPV infection in cervical low-grade lesions.
Mod Pathol, 19 (2006), pp. 384-391
[7.]
L.O. Sarian, S.F. Derchain, A. Yoshida, et al.
Expression of cycloxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix.
Gynecologic Oncology, 102 (2006), pp. 537-541
[8.]
M.I. Rosa, J.M. Fachel, D.D. Rosa, et al.
Persistence and clearance of human papillomavirus infection: a prospective cohort study.
Am J Obstet Gynecol, 199 (2008), pp. 617.e1-617.e7
[9.]
Becker D. Detecção de Chlamydia trachomatis em amostras cervicais por Reação em cadeia da Polimerase (Dissertação de Mestrado). Porto Alegre: Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Biologia Celular e Molecular. 2005. P. 90.
[10.]
H.M. Bauer, A. Hildesheim, M.H. Schiffman, et al.
Determinants of genital human papillomavirus infection in lowrisk women in Portland, Oregon.
Sex Transm Dis, 20 (1993), pp. 274-278
[11.]
F. Coutlee, P. Gravitt, J. Kornegay, et al.
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.
J Clin Microbiol, 40 (2002), pp. 902-907
[12.]
J. Cuzick, G. Terry, L. Ho, et al.
Type-specific human papillomavirus DNA in abnormal smears as a predictor of highgrade cervical intraepithelial neoplasia.
Br J Cancer, 69 (1994), pp. 167-171
[13.]
J. Bulten, I.A. van der Avoort, W.J. Melchers, et al.
p14ARF and p16INK4a, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
Gynecol Oncol, 101 (2006), pp. 487-494
[14.]
F.X. Bosh, S. de San Jose.
The epidemiology of human papilomavirus infection and cervical cancer.
Dis Markers, 23 (2007), pp. 213-217
[15.]
G.D. De Lucca, H. Marin, E. Schelover, et al.
Infeccion por Chlamydia trachomatis y Papilomavirus en mujeres con alteraciones citohistologicas de cuello uterino.
Medicina (Buenos Aires), 66 (2006), pp. 303-306
[16.]
K. Denks, E.L. Spaeth, K. Jérs, et al.
Coinfection of Chlamydia trachomatis, Uresplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia.
Scand J Infect Dis, 39 (2007), pp. 714-718
[17.]
S. Franceschi, J.S. Smith, A. Van den Brule, et al.
Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study.
Sex Transm Dis, 34 (2007), pp. 563-569
[18.]
F.D. De Paula, A.P. Fernandes, B.B. Carmo, et al.
Molecular detection of Chlamydia trachomatis and HPV infections in cervical samples with normal and abmormal cytopathological findings.
Diagn Cytopathol, 35 (2007), pp. 198-202
[19.]
P. Naucler, N.C. Chen, K. Persson, et al.
Seroprevalence of Human Papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
J Gen Virol, 88 (2007), pp. 814-822
[20.]
E. Fehér, A. Szalmás.
Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
Acta Microbiol Immunol Hung, 53 (2006), pp. 479-487
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools